Accumulation of molecules involved in α1-adrenergic signal within caveolae:: caveolin expression and the development of cardiac hypertrophy

被引:79
作者
Fujita, T
Toya, Y
Iwatsubo, K
Onda, T
Kimura, K
Umemura, S [1 ]
Ishikawa, Y
机构
[1] Yokohama City Univ, Sch Med, Dept Med & Physiol, Yokohama, Kanagawa 236, Japan
[2] Univ Med & Dent New Jersey, Dept Med, Cardiovasc Res Inst, Newark, NJ 07103 USA
关键词
diabetes; hypertrophy; receptors; signal transduction; smooth muscle;
D O I
10.1016/S0008-6363(01)00348-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Caveolin, a major protein component of caveolae, is now considered to be an inhibitor of cellular growth and proliferation. In this study, we examined the localization of the molecules involved in al-adrenergic receptor signal relative to that of caveolin in the heart and the changes in caveolin expression during the development of hypertrophy in SHR. Methods: We purified the caveolar protein fractions from rat cardiac tissues, H9C2 cells, and rat vascular smooth muscle cells. Using radioligand receptor binding assay and immunoblot analysis, we examined the distribution and the amount of alpha1-AR and caveolin. Results: Caveolin-3, the alpha1-adrenergic receptor, Gq and PLC-beta ubtypes (PLC-beta1, -beta3) were found exclusively in the caveolar fraction in the above tissues. Caveolin-3 were co-immunoprecipitated with alpha1-adrenergic receptor and Gq from the cardiac tissues. The amount of caveolin subtypes expression (caveolin-1 and -3) and the amount of the al-adrenergic receptor were examined in the hearts of SHR and age-matched WKY (4- and 24-weeks-old). The amount of caveolin-3 expression was significantly smaller in SHR at 24-weeks-old than that in SHR at 4-weeks-old and that in WKY at 24-weeks-old. Conclusions: The molecules involved in alpha1-adrenergic signaling are confined to the same microdomain as caveolin. A decrease in caveolin-3 expression may play a role in the development of cardiac hypertrophy in SHR, presumably through de-regulating the inhibition of growth signal in the hearts of SHR in the hypertrophic stage. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:709 / 716
页数:8
相关论文
共 29 条
[1]   DIFFERENTIAL DEVELOPMENT OF VASCULAR AND CARDIAC-HYPERTROPHY IN GENETIC-HYPERTENSION - RELATION TO SYMPATHETIC FUNCTION [J].
ADAMS, MA ;
BOBIK, A ;
KORNER, PI .
HYPERTENSION, 1989, 14 (02) :191-202
[2]   CONTROL OF GROWTH IN NEONATAL PIG HEARTS [J].
BEINLICH, CJ ;
MORGAN, HE .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1993, 119 (1-2) :3-9
[3]  
BOHM M, 1994, J CARDIOVASC PHARM, V23, P980
[4]   Regulation of vascular smooth muscle growth by alpha(1)-adrenoreceptor subtypes in vitro and in situ [J].
Chen, LQ ;
Xin, XH ;
Eckhart, AD ;
Yang, NY ;
Faber, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (52) :30980-30988
[5]   Interaction of a receptor tyrosine kinase, EGF-R, with caveolins - Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities [J].
Couet, J ;
Sargiacomo, M ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30429-30438
[6]   Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase [J].
Feron, O ;
Dessy, C ;
Moniotte, S ;
Desager, JP ;
Balligand, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :897-905
[7]   Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade [J].
Galbiati, F ;
Volonté, D ;
Engelman, JA ;
Watanabe, G ;
Burk, R ;
Pestell, RG ;
Lisanti, MP .
EMBO JOURNAL, 1998, 17 (22) :6633-6648
[8]  
IMAI C, 1995, BIOL PHARM BULL, V18, P1001
[9]   The adenylyl cyclases as integrators of transmembrane signal transduction [J].
Ishikawa, Y ;
Homey, CJ .
CIRCULATION RESEARCH, 1997, 80 (03) :297-304
[10]   Plasma and lipoprotein lipid composition and hepatic antioxidant status in spontaneously hypertensive (SHR) and normotensive (WKY) rats [J].
Kitts, DD ;
Yuan, YV ;
Godin, DV .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1998, 76 (02) :202-209